A project that develops a new immunotherapy based on a monoclonal antibody to treat cancer is one of the three initiatives chosen by CaixaResearch Consolidate
A project that develops a monoclonal antibody for cancer treatment, led by the Innate Immunity Research Group at the IGTP, is one of the three selected in the CaixaResearch Consolidate call of “la Caixa” Foundation to cutting-edge innovative biomedical projects.